Payer

Mississippi is the unhealthiest state in the nation for older adults  in 2023, according to the United Health Foundation's 11th annual "America's Health Rankings Senior Report."

In a wide margin, Centene shareholders have rejected a pair of proposals that took aim at executive pay, according to regulatory documents published May 15.

New drugs such as Ozempic and Wegovy can both be used to lose weight, but they're expensive and commercial insurers typically don't cover the cost, though there are options to potentially receive coverage.

Payers are expecting big gains in Medicare Advantage enrollment in 2023 as the program now represents more than half of Medicare beneficiaries. 

From signing a definitive agreement to sell an artificial intelligence platform, to shareholders rejecting a pair of proposals zeroing in on executive pay, here are eight updates about Centene that Becker's reported since April 26:

Independence Blue Cross and Philadelphia-based Penn Medicine are piloting a program that allows qualifying physicians to skip prior authorization approvals needed for ultrasounds, CT scans and PET scans. 

Aetna, UnitedHealthcare and two other insurance companies will pay a combined $4.6 million to New York state to settle allegations the companies charged unapproved rates for student insurance. 

Prominent insurtech companies — Bright Health Group, Clover Health and Oscar Health — posted a combined $281.7 million in losses in the first quarter of 2023. 

HHS' Office of Inspector General has found several Medicare Advantage plans received overpayments in recent months. 

Humana had the largest Medicare Advantage membership growth in the first quarter of 2023, according to the company's earnings report.